CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- 4 Planned sale Director sold 1,000 shares at $1.44 ($1,440)
- 8-K Event Executive or director change · Shareholder vote results
- 4 Grant or award Director acquired 28,700 shares (grant or award)
- 4 Grant or award Director acquired 28,700 shares (grant or award)
- 4 Grant or award Director acquired 28,700 shares (grant or award)
- 4 Grant or award Director acquired 28,700 shares (grant or award)
- 4 Grant or award Director acquired 28,700 shares (grant or award)
- 4 Grant or award Director acquired 28,700 shares (grant or award)
- 4 Grant or award Director acquired 28,700 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 16,488 shares at $1.34 ($22,068)
- 4 Open-market sale President and Head of R&D sold 23,890 shares at $1.34 ($31,974)
- 4 Open-market sale Chief Executive Officer sold 52,087 shares at $1.34 ($69,713)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Grant or award Director acquired 15,833 shares (grant or award)
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
Page 7 of 32 · 631 filings